Samuel R. Saks, Chief Executive Officer at JAZZ PHARMACEUTICALS INC (JAZZ), bought 23,738 shares at $13.46 ($318K) on 2007-11-12, disclosed to the SEC on 2007-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.04 | 38 | $496 | 0.2% |
| 2 | $13.31 | 500 | $7K | 2.1% |
| 3 | $13.32 | 300 | $4K | 1.3% |
| 4 | $13.39 | 900 | $12K | 3.8% |
| 5 | $13.40 | 2,900 | $39K | 12.2% |
| 6 | $13.42 | 1,400 |
| $19K |
| 5.9% |
| 7 | $13.43 | 1,000 | $13K | 4.2% |
| 8 | $13.44 | 1,800 | $24K | 7.6% |
| 9 | $13.45 | 600 | $8K | 2.5% |
| 10 | $13.46 | 1,000 | $13K | 4.2% |
| 11 | $13.41 | 9,500 | $127K | 40.0% |
| 12 | $13.42 | 900 | $12K | 3.8% |
| 13 | $13.43 | 1,900 | $26K | 8.0% |
| 14 | $13.46 | 200 | $3K | 0.8% |
| 15 | $13.47 | 800 | $11K | 3.4% |
| Total | $13.42 avg | 23,738 | $318K | 100% |
| Filing → |
| TNXP | BUY | 2015-07-17 | $75K | — | Filing → |
| ASPX | BUY | 2014-02-12 | $26K | — | Filing → |
| JAZZ | BUY | 2007-11-15 | $66K | — | Filing → |